Baxter bird flu vaccine effective in humans
March 31, 2007 by Grace Ibay
Filed under Diseases & Conditions
The H5N1 vaccine developed by Baxter International is working for humans against several strains of the virus, paving the way for the final phase of trial before the drug can be approved.
“What’s important about Phase I/II data is that the results show that Baxter’s vaccine works against many strains of the H5N1 avian flu virus without any additives [adjuvant] to boost effectiveness,” said Baxter spokesman Chris Bona. “Additives can add additional cost and they are believed to cause side effects” such as headache and fever, he added.
Baxter has developed a cell-based technology for producing flu vaccines, allowing for larger quantities with a quicker process.
[source: Chicago Tribune]
Tags: baxter, bird flu, vaccines, influenza, virus, clinical trial
